Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome X open reading frame 49 pseudogene (also known as CXorf49 pseudogene, ENSG00000283178, or LOC100289206) is classified as a human **pseudogene**[1][4]. Pseudogenes are DNA sequences that resemble protein-coding genes but are considered non-functional due to disabling mutations and lack of protein-coding potential[1][4][5]. They generally do not serve as therapeutic targets because they are not translated into functional proteins and do not show known direct roles in human disease. However, pseudogenes have been studied for their potential regulatory roles, such as acting as sources of small RNAs (e.g., siRNAs) that can modulate gene expression in certain contexts[7], but no such function is described for this particular pseudogene. No direct links to disease, biomarker use, or drug interaction exist for CXorf49 pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome X open reading frame 49 pseudogene (CXorf49 pseudogene).